Fred E. Cohen

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Fort Worth, TX
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Jeffrey Adam Novack, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Fred E. Cohen

Form 4 holding Director

Progyny, Inc.

Security class
Common Stock
Shares / value
22,693
Estimated value
$725,041
Report date
23 May 2024
Price
$31.95
Ownership
Direct
Form 4 holding Director

CareDx, Inc.

Security class
Stock Option (right to buy)
Shares / value
16,048
Estimated value
$84,573
Report date
14 Jun 2024
Price
$5.27
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Progyny, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
25,070
Estimated value
Report date
23 May 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

UroGen Pharma Ltd.

Security class
Stock Option (right ot buy)
Shares / value
10,000
Estimated value
Report date
06 Aug 2024
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount

Insider Reports Filed by Fred E. Cohen

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .